27 June 2019 : Clinical Research
TheraSling Therapy (TST) Combined with Neuromuscular Facilitation Technique on Hemiplegic Gait in Patients with Stroke
Gang Lou1BC, Caifei Fu2BE, Qingwei Du3EF, Shibo Duan4DFG, Peng Chen5ABG*DOI: 10.12659/MSM.916995
Med Sci Monit 2019; 25:4766-4772
Abstract
BACKGROUND: TheraSling therapy (TST) is a kind of rehabilitation therapy for patients with stroke in order to improving neural function. The aim of this study was to evaluate the clinical efficacy of TST combined with neuromuscular facilitation technique on hemiplegic gait in patients with stroke.
MATERIAL AND METHODS: Fifty-six patients with abnormal gait after stroke were recruited for this study and assigned randomly to either the control group (n=28) or the TST experiment group (n=28). Patients in the 2 groups all received neuromuscular facilitation technique treatment. In addition, patients in the TST experiment group were received TST. Treatments were 45 minutes a day for 6 weeks.
RESULTS: The functional ambulation category (FAC) score, improved Barthel index, Fugl-Meyer assessment (FMA), Berg balance scale (BBS), and 10 meters walking time and step length were significantly improve in both the TST experiment group and the control group after 6 weeks of treatment with a statistical difference (P<0.05). And the aforementioned indices in the TST experiment group after treatment were significantly higher than those of control group (P<0.05).
CONCLUSIONS: Lower extremity motor function and quality of life were significantly improved by TST combined with neuromuscular facilitation technique. However, the study had a small sample size, thus, further multicenter well-designed prospective randomized controlled trials are needed to confirm our findings.
Keywords: Aftercare, Recovery Room, Stroke, Electric Stimulation Therapy, Gait, Gait Disorders, Neurologic, Lower Extremity, postural balance, Quality of Life, Recovery of Function, stroke rehabilitation, Walking
Editorial
01 May 2024 : Editorial
Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)DOI: 10.12659/MSM.944927
Med Sci Monit 2024; 30:e944927
In Press
12 Mar 2024 : Clinical Research
Preoperative Blood Transfusion Requirements for Hemorrhoidal Severe Anemia: A Retrospective Study of 128 Pa...Med Sci Monit In Press; DOI: 10.12659/MSM.943126
12 Mar 2024 : Clinical Research
Tissue Inhibitors of Metalloproteinase 1 (TIMP-1) and 3 (TIMP-3) as New Markers of Acute Kidney Injury Afte...Med Sci Monit In Press; DOI: 10.12659/MSM.943500
12 Mar 2024 : Review article
Optimizing Behçet Uveitis Management: A Review of Personalized Immunosuppressive StrategiesMed Sci Monit In Press; DOI: 10.12659/MSM.943240
12 Mar 2024 : Clinical Research
Metabolomic Alterations in Methotrexate Treatment of Moderate-to-Severe PsoriasisMed Sci Monit In Press; DOI: 10.12659/MSM.943360
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952